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ABSTRACT
Objective: The main objective of this study was to assess tumor necrosis factor-α (TNF)-α and cyclooxygenase enzymes (COX) inhibition potency of 
Tamarindus indica Linn. in comparison to standard drug (indomethacin).
Methods: Three plants are selected for the studies, namely: Aloe vera (L.), Terminalia chebula Reitz., and T. indica Linn. Estimation of TNF-α in serum 
(at 1:10 dilution in PBS) was performed using the immunoenzymatic (ELISA) technique. COX inhibitor screening assay kits were used for estimation 
of COX.
Result: All three plant extracts showed a potent significant inhibition of the COX enzyme as compared to the positive control and standard drug when 
the animal was administered with 400 mg/kg. These studies indicate that the T. indica plant extract showed significant COX inhibition even at low 
dose. All the extracts were effective anti-inflammatory in nature, however, T. indica extracts at a dose of 400 mg/kg were found to be most potent. It 
was found to be comparable with that of Indomethacin 10 mg/kg body weight.
Conclusion: The anti-inflammatory activity expressed by all the three plants A. vera (L.), T. chebula Reitz., and T. indica L. Among all three plants 
T. indica (L) was found to be more active against both TNF-α and COX, and it was comparable to standard drug Indomethacin. Need further studies to 
elucidate the exact secondary metabolite by which these plants express this activity.
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INTRODUCTION
Inflammation is a defensive process that protects the body against 
harmful stimuli and hastens the recovery process [1]. The stimulus 
may be in the form of a wound, a pathogenic bacterium or virus or an 
endogenous trigger. This can be recognized by redness, pain, swelling, 
immobility, and heat [2]. The process of inflammation is to activate the 
immune system to the site of injury by increasing the blood supply and 
altering the permeability of the blood vessels which accounts for some 
the above-mentioned characteristics such as the swelling and heat [3]. 
The inflammatory response is complex as it involves a group of reactions 
that include enzyme activation, innate immune cell activation and 
migration, release of reactive oxygen species and tissue repair that act to 
remove the cause and repair the damage of the injury [4]. The migrated 
immune cells are called macrophage and T lymphocyte cells that become 
activated to release pro-inflammatory cytokines. The cytokines are 
released to magnify inflammatory process at the site of injury to resolve 
the source of injury [5]. Inflammation is part of the innate immune 
response which means that is it not specific for any particular cause of 
injury. The non-specific nature of the response means that the reactions 
are similar despite the cause of the injury which can be detrimental if 
the injury is persistent. Therefore, the inflammatory reactions must be 
actively regulated to prevent unnecessary impairment to tissues [6]. The 
improper regulation of the process for the resolution of injury can lead 
to a perpetual state of inflammation which can become chronic.
Inflammation is mediated by chemokines that include tumor necrosis 
factor-α (TNF)-α, nuclear factor kappa beta (NFΚβ), interferon (IFN)-γ, 
nitric oxide (NO), and interleukins. The mediators are from different 
sources and influence different reactions within the inflammatory 
process. Most of the inflammatory mediators are newly synthesized 
in the injured tissues or by the floated immune cells during an 
inflammatory event. Pathological organisms such as bacteria activate 
NFΚβ through receptors found on macrophages through several 
signaling pathways. The activated macrophages can release TNF-α 
which is responsible for the up-regulation of the production of other 
inflammatory mediators that include prostaglandins and NO. The 
membrane-bound glycoproteins, cyclooxygenase (COX) enzymes are 
found in the endoplasmic reticulum [7]. The cell membrane-bound 
arachidonic acid is converted into prostaglandin H2 by COX enzymes. 
Arachidonic acid is a precursor molecule for all the eicosanoid 
molecules that include prostaglandins and thromboxanes. There are 
two main types of COX enzymes; namely, COX1 and COX2 that differ 
mostly in their array of expression.
The current approaches for the treatment of the inflammatory condition 
are mainly interrupting the synthesis or action of critical mediators that 
drive the host’s response to injury. Steroidal, Narcotic and nonsteroidal 
anti-inflammatory drugs (NSAIDs) are the current treatment approach 
for inflammatory disorders. However, the available drugs have reduced 
efficacy against inflammatory conditions due to adverse effects and 
relatively high potency. For example, steroidal drugs are in use as anti-
inflammatories due to their specific mechanisms of action that are 
considered to be responsible for their adverse effects as well. Steroidal 
anti-inflammatories inhibit basal physiological function such as 
leukotriene inhibition. The unwanted effects reported as hypertension 
due to the similarity of the steroidal drugs to the steroid hormones. 
The nonsteroidal drugs have relatively fewer and less adverse effects 
than the steroidal that include gastrointestinal bleeding and improper 
clotting of blood [8].
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Therefore, there is a need for treatment options that have minimum 
side effect and maximum efficacy and must be comparable to a 
standard drug. To fulfill this demand currently, researchers are looking 
for alternate source of drug rather than synthetics one. The best option 
is an herbal crude drug that is frequently used in rural part of India 
as a folk medicine. Present research work layout in such a manner to 
explore the molecular basis of the particular activities that can inhibit 
expression of TNF-α and COX.
MATERIALS AND METHODS
Plant collection
On the basis literature review three plants are selected for the 
studies:
1. Aloe vera (L.)
2. Terminalia chebula Reitz.
3. Tamarindus indica L.
After collection of all three plants it was identified and authenticated 
by a pharmacologist and letter a voucher specimen (No. IU/PHAR/
HRB/7/11) was deposited at the Department of Pharmacognosy 
Integral University, Lucknow, Uttar Pradesh, India. Aqueous extractions 
of all these three plants were done according to standard procedure.
A. vera Linn
For aqueous extraction of A. vera leaves were collected, washed in 
cold water; spines around the leaves were removed using a blade 
after which the leaves were sliced by knife. 200 g of the sliced material 
were mixed with of distilled water and blended in an electric blender 
for 3 min to obtain 400% (w/v) extract. The blended material was 
squeezed through a muslin cloth. The filtrate was freeze-dried at −50°C 
under vacuum using a lyophiliser and kept at −20°C until use. Various 
dose levels of the A. vera were made by reconstituting the extract at 
concentration of 1% (w/v) [9].
T. chebula Retiz
The fruits of T. chebula were used for the experiment. Preparation of 
extract of T. chebula shade dried fruits of T. chebula was grounded into 
a fine powder in an electric grinder. About 890 g of grinded powdered 
material were extracted with 80% ethanol at a temperature of 60°C 
for about 48 h. The mixture was filtrated. While volume is reduced, it 
was then poured in watch glass of large surface area to make it more 
condensed and allow the rest solvent to evaporate. While the condensed 
filtrate turned into a gummy concentrate, it was obvious that we found 
the crude ethanolic extract. The ethanolic extract was further evaporated 
to dryness to obtain the dried ethanolic extract. The percentage yield of 
extract was 12.1% w/w with respect to the original air-dried powder 
was obtained [10]. the extract was finally stored in airtight container 
at 2°C–8°C for further use during the experiment [11]. The dose was 
adjusted as per dosing schedule following standard procedure.
T. indica L
The extraction was performed using maceration technique [12]. The 
coarse powder of T. indica seeds (100 g) was subjected to maceration 
for 72 h at room temperature using 500 ml methanol. The extract was 
filtered, and the solvent was evaporated under vacuum to obtain a 
powdered residue. After that during experiment dose was adjusted as 
per dosing schedule following standard procedure.
Preparation of solutions (extract and standard)
To evaluate the activities of different plant extract, two different 
concentration of extract were used, 200 and 400 mg/kg body weight 
(b.w.) for each plant extract. For the preparation of standard solution 
indomethacin 10 mg/kg b.w. adjusted by dissolving in distilled water.
Qualitative analysis of phytochemical constituents
Preliminary chemical tests were carried out for the all extracts of plants 
to identify different phytochemical constituents present in the plants as 
per the protocol described [13].
Assay of COX inhibition
Ultrapure water, COX inhibitor screening assay kits and lipoxygenase 
(LOX) inhibitor screening assay kits were obtained from Cayman 
Chemicals, USA. All reagents and solvents used were of analytical 
grade from Sigma-Aldrich, India, and from HiMedia Laboratories, 
India. 96 well plates were read on the iMark Microplate absorbance 
reader and washed with the model 1575 immunowash microplate 
washer from BioRad, India. Spectrophotometric assays were conducted 
on ultraviolet 1800 spectrophotometer from Shimadzu, Japan. The 
COX inhibitor screening directly measures prostaglandin F2 alpha 
by stannous chloride reduction of COX-derived prostaglandin H2 
produced in the COX reaction [14]. The reaction system consists of 
reaction buffer, heme, enzyme and plant extract pre-incubated at 
37°C for 20 min with background and enzyme controls. The reaction 
was started with the incorporation of arachidonic acid and incubated 
for 2 min at 37°C temperature. The reaction was stopped with add of 
saturated stannous chloride solution and 5 min at room temperature 
(25°C). The prostaglandins are quantified by EIA. An aliquot of these 
reactions was added to the precoated plates in triplicates together with 
AChE tracer and antiserum and incubated for 18 h at room temperature 
on an orbital shaker. The plate was finally developed with Ellman’s 
Reagent and kept on an orbital shaker in the dark at room temperature 
for 1 h. The absorbance was read at 420 nm. The data were plotted as 
standard bound/maximum bound versus log concentration using a 
4-parameter logistic curve fit. The concentration of each sample was 
determined from a standard curve with appropriate dilutions and used 






The percent inhibition was plotted against the inhibitor concentration 
to determine the IC50 value (concentration at which there was 50% 
inhibition). The dosing scheme for all the plant extracts, control and 
standard followed same as for the other experiments [15].
Estimation of TNF-α in serum
Estimation of TNF-α in serum (at 1:10 dilution in PBS) was performed 
using the immunoenzymatic (ELISA) technique, taking advantage of 
high sensitivity Quantikine HS ELISA human TNF-α (R and D systems, 
USA) kits, manifesting mean minimum detectability of 0.106° pg/ml. 
The absorbance value noted at λ max 490° nm, obtained using reader 
250 (bioMerieux, France). The final result of the studied cytokine 
concentration involved a product of the readout on the standard curve 
and the applied dilution (×10) [15,16].
Acute toxicity study
The oral acute toxicity studies of all three plants extract where examined 
as per Organization for Economic Cooperation and Development (OECD) 
guideline 423 on BALB/c mice (20–30 g) [17], where the limit test dose 
of 4000 mg/kg was used. All the animals were kept at overnight fasting 
before every experiment with free excess to water. The animals were 
divided into four groups, each comprising five animals. The 1st group 
served as a negative control, while 2nd, 3rd, and 4th was considered as 
tested groups received orally plant extract (dissolved in normal saline) 
extract at a dose of 300 mg/kg, 2000 mg/kg, and 4000 mg/kg. Before 
dose administration, the b.w. of each animal was determined, and the 
dose was calculated according to the b.w. The animals were observed 
for any toxic effect for first 4 h after the treatment period. Further 
animals were investigated for a period of 3 days for any toxic effect. 
Behavioural changes and other parameters such as body weight (b.w), 
urination, food intake, water intake, respiration, convulsion, tremor, 
temperature, constipation  changes in eye and skin colors.
Sub-acute toxicity study
The oral sub-acute toxicity study was carried as per OECD guideline 
407 (OECD guidelines for the testing of chemicals). The adult healthy 
BALB/c mice (20–30 g) of each sex were divided into three groups of 
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five animals each and were kept under standard conditions. Group I 
was treated as control and the other two groups which were considered 
as tested groups received the plant extract at a dose of 600 and 
1000 mg/kg b.w., respectively, for 28 consecutive days [18].
Animals and experimental design
Animal handling during the experimental procedure was done as per 
university guidelines and animal ethics. The rats were allowed free 
access to standard commercial rat pellets (Hindustan Lever Li, India). 
Clean water was provided ad libitum throughout the experimental 
periods.
In all the experiments, animals were categorized as following:
Group I: Control group received only 1 ml saline water (0.91% w/v).
Group II: 200 mg/kg b.w as per oral for each plant extract.
Group III: 400 mg/kg b.w as per oral for each plant extract.
Group IV: 10 mg/kg b.w as per oral as a standard drug (Indomethacin)
Statistical analysis
Data are summarized as mean ± standard deviation (SD). All studies 
compare between standard and at two different dose level for all 
the three plants were done using one-way ANOVA and p<0.05 was 
considered statistically significant.
RESULT AND DISCUSSION
Qualitative analysis of phytochemical constituents
A (+) score was recorded if the reagent produced only a slight positive 
reaction; a (++) score for a definitive positive reaction and a (+++) score 
was recorded if heavy reactions were obtained. Statistical analyses: 
In all the studies, the values of three independent experiments were 
expressed as mean ± SD for n determinations where n=3 unless 
otherwise stated. The result is shown in a tabular form for all plant 
extract in Table 1.
Screening of plant extracts for effect on COX activity
All plant extracts were used as per protocol to study the effect on the 
activity of COX, and the results are as shown in Table 2.
All three plant extracts showed a potent significant inhibition of the 
COX enzyme as compared to the positive control and standard drug 
when the animal was administered with 400 mg/kg. These studies 
indicate that the T. indica plant extract showed significant COX 
inhibition even at low dose. The anti-inflammatory activities of this 
plant extract may be due to potential inhibition COX even at low dose. 
The results presented in this section have conclusively established the 
presence of bioactive molecules in all these three plant extracts capable 
of dual inhibition of COX enzymes involved in the biosynthesis of pro-
inflammatory leukotrienes and prostaglandins. The identification of 
secondary metabolites present in plant extracts could provide lead-
like compounds involved in the anti-inflammatory activity reported in 
these plant extracts. The phytochemical analysis of these all three plant 
extracts indicates the presence of terpenoids, saponins, and alkaloids. 
The presences of flavonoids are also found in all the three plant extracts. 
The extracts exhibit weak positive results for cardiac glycosides, tannins, 
and reducing sugars. The medicinal plants used for the present study 
are routinely used in Ayurvedic and Unani formulations and folkloric 
medicines in a different part of India. The findings of the present study 
reveal the presence of potential bioactive molecules capable of dual 
inhibition of COX enzymes. The findings of the present study open up 
new avenues for identification of bioactive molecules which could be 
used for development of safer anti-inflammatory molecules compared 
to current anti-inflammatory NSAIDs. The exact nature of the activity 
of the plant extract and the bioactive compounds involved are being 
investigated.
Serum TNF–α estimation
All the three plants extract showed the inhibition of TNF-α, and it is 
dose-dependent but in case T. indica showed highest % inhibition. The 
result showed in a tabular form at a different dose for different plant 
extract in Table 3.
This study revealed an anti-inflammatory effect of all three plant 
extracts. All the extracts were effective anti-inflammatory in nature, 
however, T. indica extracts at a dose of 400 mg/kg were found to be 
most potent. It was found to be comparable with that of Indomethacin 
10 mg/kg b.w. It has been reported that various mediators are released 
by carrageenan in the rat paw. The initial phase is attributed to the 
release of histamine and 5-hydroxytryptamine. A second phase is 
mediated by kinins, and finally, in a third phase, the mediator is 
suspected to be prostaglandin.
The chemical analysis of all plant extracts revealed the presence of 
flavonoids. A variety of in vitro and in vivo experiments have shown that 
selected compounds of this large group of naturally occurring products 
possessed various important pharmacological activities including 
anticancer, anti-inflammatory, and anti-allergic activities [19].
Studies have shown that the anti-inflammatory activity of flavonoids 
is mediated by the inhibition of arachidonic acid metabolizing 
enzymes, COX, and LOX as well as by antioxidative properties. It has 
been previously demonstrated that several flavonoids such as flavone 
chrysin, 3-hydroxyflavone, and galangin, some chalcones (having 
a3–4 hydroxyl substitution) were COX inhibitors. In TNF-α estimation 
using ELISA, among all extract showed a significant decrease in 
TNF-α production in a dose-dependent matter. This further proves 
Table 1: Phytochemical investigation of plant extract
Name of plant Alkaloid Flavonoid Cardiac glycoside Saponins Terpenoids Tannin Reducing sugar
A. vulgaris + ++ ++ ‑ + ++
T. chebula + ++ + + + +++ ‑
T. indica ++ +++ + + ‑ ++ +
(−) - Not presence (+) - Low presence, (++) - Moderate presence, (+++) - High presence. A. vulgaris: Aloe vulgaris, T. chebula: Terminalia chebula, T. indica: Tamarindus 
indica
Table 2: Effect of plants extracts on COX activity
Sl. No. Plant extracts % inhibition of COX at 200 mg/kg dose % inhibition of COX at 400 mg/kg dose
1 Control 0%
2 A. vulgaris Lam. 20.98±1.68 29.13±1.03
3 T. chebula Retiz. 32.67±1.87 43.17±1.99
4 T. indica 53.94±2.50 62.68±1.01
5 Indomethacin standard at standard dose 
10 mg/kg b.w.
75.15±0.965
n=3, ±: Standard deviation. A. vulgaris: Aloe vulgaris, T. chebula: Terminalia chebula, T. indica: Tamarindus indica, COX: Cyclooxygenase, b.w: Body weight
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that T. indica regulates the inflammation by a significant decrease of 
pro-inflammatory cytokines, i.e., TNF-α which mediates many crucial 
events for the initiation of acute, sub-acute, and chronic inflammation. 
Furthermore, it is having an anti-proliferative activity and the potential 
to directly react with free radicals. The present research work validates 
the traditional claim of this plants on modern scientific line.
Acute toxicity study
The acute toxic effect of all three plant extracts was determined as per 
the OECD guideline 423, where the limit test dose of 4000 mg/kg was 
used. No treatment-related toxic symptom or mortality was observed 
after oral administration of the tested plant extract at a dose of 300, 
2000, and 4000 mg/kg. The general behavioral of the extract treated 
animals, and control group was observed first for a short period 
(4 h) followed by long period (72 h), did not display any drug-related 
changes in behavior, breathing, skin effects, water consumption, and 
impairment in food intake and temperature. Therefore, the extract 
seems to be safe at a dose level of 4000 mg/kg, and the LD50 was 
considered be >4000 mg/kg. However, there was sign of sedation, 
lethargy, and drowsiness after the administration of plant extract 
at a dose of 0.6 g/kg and 1.0 g/kg, compared to control group. The 
parameters observed for acute toxicity study after the administration 
of these plant extract compared with normal group are presented in 
Table 4.
Sub-acute toxicity study
The sub-acute toxic study of all the three plant extract was determined 
as per OECD guideline 407. All the tested group animals treated 
with plant extract at a dose of 600 and 1000 mg/kg dairy survived 
throughout the 28 days. No clinical toxicity signs were observed in 
all the three plant treated group compared to the control group. In 
conclusion, the pharmacological activities of all the three plants of 
its use in folk medicine as antipyretic activity, analgesic activity and 
anti-inflammatory activity but further studies are needed to elucidate 
the exact mechanism by which secondary metabolite of these plants 
express these activities.
There were no mortality or morbidity observed in animals through the 
14 days period following single oral administration at all selected dose 
levels for all the plant extract. No observed adverse effect limit was 
>5000 mg/kg when administered orally.
CONCLUSION
The anti-inflammatory activity expressed by all the three plants. 
However, T. indica L. is more active against TNF–α and COX, and it was 
comparable to Indomethacin. Need further studies to elucidate the 
exact secondary metabolite by which these plants express this activity.
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